— Know what they know.
Not Investment Advice

XAIR NASDAQ

Beyond Air, Inc.
1W: -1.1% 1M: -22.1% 3M: -67.9% YTD: +257.5% 1Y: +16.1% 3Y: -94.4% 5Y: -98.8%
$2.82
-0.11 (-3.75%)
 
Weekly Expected Move ±11.1%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 35 · $2.0M mcap · 703354 float · 30.85% daily turnover · Short 50% of daily vol

Supply Chain Overview

12 relationships
12
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2021-05-26
Earliest Filing
2025-11-05
Latest Filing
partner: 5 customer: 3 acquirer: 1 investor: 1 target: 1 licensee: 1

Counterparties (Filed by XAIR)

12 relationships

Companies named in XAIR's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Beyond Air, Inc. XAIR acquirer Company issuing and selling Common Stock to Investor 2025-11-05 View
Streeterville Capital, LLC — investor Investor purchasing up to $20,000,000 of Common Stock 2025-11-05 View
BTIG, LLC — partner Sales agent for the at-the-market stock sale agreement. 2025-02-14 View
Beyond Air, Inc. XAIR customer Borrower in the loan agreement 2024-11-06 View
BEYOND AIR, INC. XAIR customer Borrower in the loan agreement 2024-06-27 View
BEYOND AIR LTD. XAIR partner Israeli guarantor for the loan 2024-06-27 View
Beyond Air, Inc. XAIR target Company entering into amendment to terminate agent participation 2024-03-01 View
Oppenheimer & Co. Inc. OPY partner Agent whose participation is being terminated 2024-03-01 View
BEYOND AIR, INC. XAIR customer Primary borrower in the loan agreement 2023-06-20 View
BEYOND AIR LTD. XAIR partner Israeli guarantor providing security for the loan 2023-06-20 View
Oppenheimer & Co. Inc. OPY partner Sales agent for the common stock offering 2022-02-04 View
Circassia Group plc — licensee Settlement agreement regarding LungFit PH commercialization rights and royalty payments 2021-05-26 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-24 Material Agreement; Officer/Director Change; Exhibits Agreement View
2026-08-18 Earnings Release; Regulation FD; Exhibits View
2026-08-06 Other Events View
2026-07-31 Material Agreement; Unregistered Equity Sales; Other Events; Exhibits Agreement View
2026-07-09 Bylaws Amendment; Exhibits View
2026-06-26 Earnings Release; Bylaws Amendment; Regulation FD; Exhibits View
2026-06-22 Shareholder Vote; Other Events View
2026-06-01 Other Events; Exhibits View
2026-04-15 Other Events View
2026-04-10 Delisting Notice View
2026-04-01 Material Agreement; Officer/Director Change; Regulation FD; Exhibits Agreement View
2026-02-13 Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex View
2026-02-02 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2026-01-20 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin Agreement View
2026-01-15 Other Events; Financial Statements and Exhibits View
2025-12-30 Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; Agreement View
2025-12-11 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-11-28 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2025-11-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-05 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms